Related Experiment Video
Updated: Aug 14, 2025
04:57
Establishing a Competing Risk Regression Nomogram Model for Survival Data
Published on: October 23, 2020
10.3K
Bayesian hierarchical model-based network meta-analysis to overcome survival extrapolation challenges caused by data
Bart Heeg1, Andre Verhoek1, Gabriel Tremblay2
1Cytel RWAA, Weena 316, 3012 NJ, Rotterdam, The Netherlands.
Journal of Comparative Effectiveness Research
|January 18, 2023
Summary
Bayesian hierarchical Weibull mixture cure network meta-analysis (BH-WMC-NMA) offers improved long-term survival predictions for metastatic non-small-cell lung cancer therapies. This method impacts cost-effectiveness and reimbursement decisions.
Area of Science:
- Oncology
- Biostatistics
- Health Economics
Background:
- Metastatic non-small-cell lung cancer (NSCLC) treatment decisions require accurate long-term survival predictions.
- Standard Weibull mixture cure network meta-analysis (WMC-NMA) is a statistical method used to compare multiple treatments.
- Bayesian hierarchical modeling offers a robust framework for complex meta-analyses.
Purpose of the Study:
- To evaluate the performance of Bayesian hierarchical WMC-NMA (BH-WMC-NMA) compared to standard WMC-NMA for predicting long-term survival in advanced NSCLC.
- To assess the impact of BH-WMC-NMA on estimated cure rates and incremental life years (LY) for different therapies.
- To understand how these advanced statistical models influence cost-effectiveness and potential reimbursement decisions.
Main Methods:
- Utilized data from four clinical trials involving patients with previously treated metastatic NSCLC and PD-L1 expression >1%.
- Compared docetaxel with immune checkpoint inhibitors: nivolumab, pembrolizumab, and atezolizumab.
- Applied both standard WMC-NMA and BH-WMC-NMA, assuming cure parameters within treatment classes share a common distribution.
Main Results:
- BH-WMC-NMA predicted higher cure rates for docetaxel (0.06 vs 0.03) and pembrolizumab (0.12 vs 0.07) compared to standard WMC-NMA.
- Incremental life years varied between the two methods, with BH-WMC-NMA suggesting different survival benefits for certain therapies.
- BH-WMC-NMA results indicated potential shifts in cost-effectiveness ratios, influencing treatment value assessments.
Conclusions:
- BH-WMC-NMA provides a more refined estimation of long-term survival and cure rates in advanced NSCLC.
- The choice of meta-analysis methodology significantly impacts the predicted incremental life years and cost-effectiveness.
- Findings suggest BH-WMC-NMA is a valuable tool for informing clinical and reimbursement decisions in oncology.
Related Concept Videos
01:14Parametric Survival Analysis: Weibull and Exponential Methods
524
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
524
01:20Comparing the Survival Analysis of Two or More Groups
247
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
247
01:19Survival Tree
131
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
131
01:18Introduction To Survival Analysis
330
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
330
01:15Assumptions of Survival Analysis
172
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
172
01:24Kaplan-Meier Approach
221
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
221